Berti, Alvise
 Distribuzione geografica
Continente #
NA - Nord America 691
AS - Asia 513
EU - Europa 510
OC - Oceania 7
AF - Africa 4
Totale 1.725
Nazione #
US - Stati Uniti d'America 685
SG - Singapore 350
IT - Italia 294
CN - Cina 99
RU - Federazione Russa 50
GB - Regno Unito 49
ID - Indonesia 34
DE - Germania 33
FI - Finlandia 22
NL - Olanda 12
ES - Italia 10
IN - India 10
AT - Austria 8
IE - Irlanda 8
SE - Svezia 8
AU - Australia 7
MY - Malesia 7
CA - Canada 6
FR - Francia 6
JP - Giappone 6
EG - Egitto 4
UA - Ucraina 3
VN - Vietnam 3
CH - Svizzera 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
LT - Lituania 1
RS - Serbia 1
TW - Taiwan 1
Totale 1.725
Città #
Singapore 297
Santa Clara 226
Columbus 186
Trento 177
Ashburn 101
Moscow 41
Rome 39
Jakarta 34
Helsinki 22
Washington 20
Dallas 19
Castello Molina di Fiemme 15
Milan 12
New York 12
Kilburn 11
London 11
Shanghai 10
Los Angeles 9
Pamplona 9
Beijing 7
Hyderabad 7
Stockholm 7
Ansbach 6
Fort Worth 6
Wilmington 6
Dublin 5
Vicenza 5
Acton 4
Cagliari 4
City of Westminster 4
Como 4
Daiano 4
Frankfurt am Main 4
Jiaxing 4
New Bedfont 4
Nuremberg 4
Paris 4
Princeton 4
Shenzhen 4
Springfield 4
Velletri 4
Vienna 4
Xiamen 4
Cairo 3
Can Tho 3
Castelfranco Veneto 3
Chiswick 3
Council Bluffs 3
Hollywood 3
Hounslow 3
Katwijk aan Zee 3
Munich 3
Novosibirsk 3
Perugia 3
Petaling Jaya 3
Shah Alam 3
Shijiazhuang 3
Tianjin 3
Tokyo 3
Yokkaichi 3
Amsterdam 2
Ann Arbor 2
Annapolis Junction 2
Boydton 2
Cambridge 2
Hangzhou 2
Kozhikode 2
Liverpool 2
Newcastle 2
Palermo 2
Perth 2
San Francisco 2
San Mateo 2
Toronto 2
Zhengzhou 2
Zurich 2
Adelaide 1
Baoding 1
Bassano del Grappa 1
Belgrade 1
Berlin 1
Bessemer 1
Boardman 1
Bologna 1
Bolzano 1
Bothell 1
Brno 1
Brussels 1
Buffalo 1
Changzhou 1
Clifton 1
Daejeon 1
Dalian 1
Fairfield 1
Falkenstein 1
Fuyang 1
Gatchina 1
Groningen 1
Guiyang 1
Gurugram 1
Totale 1.471
Nome #
Autoreactive B Cells in ANCA-Associated Vasculitis 76
Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? 42
Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations 39
Impulse oscillometry for the evaluation and management of pediatric asthma 34
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 32
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 31
Disease and Treatment-Related Morbidity in Young and Elderly Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis 31
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 27
The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study 27
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions 26
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 25
Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study 25
Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes 25
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 25
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis 25
Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls 25
A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis 25
Chronic Rhinosinusitis in Eosinophilic Granulomatosis With Polyangiitis: Clinical Presentation and Antineutrophil Cytoplasmic Antibodies 24
The Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis 24
Asthma and COVID-19: a dangerous liaison? 24
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: A systematic literature review 24
Allergic rhinitis and COVID-19: friends or foes? 23
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. 23
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 23
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 23
Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis 23
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 22
Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab 22
A second case of pericardial mesothelioma mimicking systemic lupus erythematosus in the literature in over 30 years: a case report 22
Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study 22
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 22
Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease 21
Tocilizumab in patients with multisystem Erdheim-Chester disease 21
BRAFV600E-mutation Is Invariably Present and Associated to Oncogene-Induced Senescence in Erdheim-Chester Disease 21
Current and Future Treatment Options for Eosinophilic Granulomatosis With Polyangiitis 21
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 21
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 21
Remission maintenance in ANCA-associated vasculitis: does one size fit all? 20
The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis 20
Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura 20
Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature 20
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor 19
Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis 19
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 19
Cardiovascular manifestations of Erdheim-Chester disease 19
Severe/uncontrolled Asthma and Overall Survival in Atopic Patients With Eosinophilic Granulomatosis With Polyangiitis 19
Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 19
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity 19
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 19
Drug induced exfoliative dermatitis: state of the art. 19
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 19
Orbital masses in ANCA-associated vasculitis: an unsolved challenge? 18
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 18
Hypertrophic Cardiomyopathy Secondary to Hepatitis C Virus-Related Vasculitis 18
Predicting Disease Activity in Systemic Vasculitides: On the Hunt for Potential Candidates 18
Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors of Long-term Asthma Severity 18
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. 18
Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016 17
Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers 17
Juxta-vertebral lesions in granulomatosis with polyangiitis 17
Erdheim-Chester disease 17
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 17
Interleukin-6 in ANCA-associated Vasculitis: Rationale for Successful Treatment With Tocilizumab 17
EBV-induced lymphoproliferative disorders in rheumatic patients: A systematic review of the literature 17
Prevalence and features of IOS-defined small airway disease across asthma severities 17
Severe asthma: One disease and multiple definitions 17
Small airway dysfunction and impulse oscillometry in adult patients with asthma: recent findings 17
The Severe Long-term Outcomes of “Non-severe” Eosinophilic Granulomatosis with Polyangiitis. 16
Efficacy and safety of biological agents in adult-onset Still's disease 16
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma 16
Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis 16
Diagnosing and treating ANCA-Associated vasculitis: An updated review for clinical practice 16
Treatments for giant cell arteritis: Metaanalysis and assessment of estimates reliability using the fragility index 16
The survival of patients with alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody–associated vasculitis 15
Targeting the interleukin-5 pathway in EGPA: Evidence, uncertainties and opportunities 15
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 15
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media 15
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis 15
Update on the epidemiology, risk factors, and outcomes of systemic vasculitides 15
Small-airway dysfunction in paediatric asthma 15
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 15
Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma 15
Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease 14
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 14
IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients 14
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 14
Small Airways: The “Silent Zone” of 2021 GINA Report? 14
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients 14
Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series 14
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 13
Small airway dysfunction and poor asthma control: a dangerous liaison 13
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis 13
Dr. Berti et al reply 13
Assessment Of Tocilizumab In The Treatment Of Cancer Cachexia 13
Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: A perfect storm 13
Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely 13
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia 13
Orthopnea with platydeoxia secondary to prominent Eustachian valve 13
Kaposi's Sarcoma in a Patient With Eosinophilic Granulomatosis With Polyangiitis While Taking Mycophenolate Mofetil 12
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis 10
Totale 2.003
Categoria #
all - tutte 18.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 71
Totale 18.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 2 9 3 2 7 2 5 3 4
2022/2023328 4 0 0 1 0 0 0 0 0 123 107 93
2023/2024322 1 1 32 13 53 83 27 12 3 27 19 51
2024/20251.347 63 22 302 494 156 300 10 0 0 0 0 0
Totale 2.034